Launch event: European Antibiotic Awareness Day
On 18 November 2019, ECDC marked the 12th European Antibiotic Awareness Day at Europahuset in Stockholm, Sweden. Organisations and governmental bodies responsible for tackling antibiotic resistance are invited to join.Find out more
On any given day 1 in 3 patients received at least one antimicrobial
Some of this use may be unnecessary and lead to the spread of antimicrobial resistance.ECDC point-prevalence surveys
Latest antimicrobial resistance data
Interactive reports with the latest data in Europe in the ECDC Surveillance AtlasView Atlas
Directory of online resources
The directory lists strategies, guidance documents and training courses on the prevention and control of antimicrobial resistance and healthcare-associated infections available online.View web directory
The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2017/2018
First-of-its kind survey reveals gaps in European healthcare workers’ knowledge and attitudes about antibiotics
Threats and outbreaks
Risk assessments and rapid risk assessments related to the spread or occurrence of highly antibiotic-resistant bacteria
Systematic reviews, expert opinions and public health guidance on antimicrobial resistance
Communication toolkits for the European Antibiotic Awareness Day offer template campaigns materials promoting responsible use of antibiotics
Antimicrobial resistance in specific diseases
Antimicrobial resistance - Escheria coli
Escherichia coli resistance to major antibiotics is increasing in almost all countries in Europe. E. coli causes urinary tract and more serious infections and is one of the most common bacteria causing infections.
Antimicrobial resistance - Tuberculosis
In EU, only 1 in every 3 MDR TB patients has a successful treatment outcome; more than half either die, fail treatment or default (stop taking treatment). XDR TB has even worse treatment outcomes: only 1 in 4 patients finishes treatment successfully.
Antimicrobial resistance - Salmonellosis
Multi-drug resistant Salmonella bacteria continue to spread across Europe, show the latest data on resistance in bacteria in humans, food and animals issued by ECDC and EFSA. There’s evidence of resistance to the antimicrobial colistin in Salmonella among poultry in the EU - this last-resort drug may soon no longer be effective for treating severe human infections with Salmonella.
Antimicrobial resistance/ microbiology - Gonorrhoea
The surveillance of gonococcal antimicrobial susceptibility surveillance in Europe is essential for detecting emerging and increasing antimicrobial resistance and making quality-assured data available to inform revisions of treatment guidelines. ECDC coordinates the Euro-GASP network.
Disease programmes and networks
The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area